RxDoctor Payments Data

Nicholas Giordano, MD

Pain Medicine · Melbourne, FLNPI 1336482694

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 62.3% of it on its own, with 19 other manufacturers making up the rest. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,823in general payments, 2019–2025

Across 348 payments — averaging $68.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$15K
  • Vertiflex, Inc.$3K
  • Boston Scientific$3K
  • Vertos Medical, Inc.$2K
  • Medtronic$759
  • Curonix LLC$249
  • plus $1K from 14 others

What the payments were for

  • Speaking & faculty fees$6,16326%
  • Travel & lodging$3,00813%
  • Food & beverage$14,10459%
  • Education$5492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,823 in reported general payments places this provider in the 90th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$1,109,026
Medicare patients
641
Services billed
29,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,162$44,652
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,168$29,021
Pregabalin1,158$15,715
Naloxone Hcl170$11,092
OxycontinOxycodone Hcl13$7,615
Oxycodone Hcl345$5,748
Buprenorphine30$5,073
Tramadol Hcl449$3,937
Morphine Sulfate ErMorphine Sulfate162$3,651
Fentanyl17$3,079
Tizanidine Hcl281$2,686
Gabapentin211$2,443
Acetaminophen-CodeineAcetaminophen With Codeine154$2,406
Cephalexin17$1,736
Methocarbamol92$1,084

Paid to pharmacies, not to this prescriber.

Other pain medicine in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →